1. Home
  2. ACRE vs SMTI Comparison

ACRE vs SMTI Comparison

Compare ACRE & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ares Commercial Real Estate Corporation

ACRE

Ares Commercial Real Estate Corporation

HOLD

Current Price

$4.95

Market Cap

254.1M

Sector

Real Estate

ML Signal

HOLD

Logo Sanara MedTech Inc.

SMTI

Sanara MedTech Inc.

HOLD

Current Price

$23.32

Market Cap

208.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACRE
SMTI
Founded
2011
1982
Country
United States
United States
Employees
N/A
108
Industry
Real Estate Investment Trusts
Medical/Dental Instruments
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
254.1M
208.8M
IPO Year
2011
2008

Fundamental Metrics

Financial Performance
Metric
ACRE
SMTI
Price
$4.95
$23.32
Analyst Decision
Hold
Strong Buy
Analyst Count
4
2
Target Price
$5.38
$34.00
AVG Volume (30 Days)
393.8K
39.6K
Earning Date
05-07-2026
05-12-2026
Dividend Yield
11.58%
N/A
EPS Growth
26.17
N/A
EPS
1.35
0.05
Revenue
$54,833,000.00
$15,586,976.00
Revenue This Year
N/A
$17.31
Revenue Next Year
$16.28
$12.48
P/E Ratio
$3.66
$459.60
Revenue Growth
N/A
32.47
52 Week Low
$4.05
$16.05
52 Week High
$5.89
$35.70

Technical Indicators

Market Signals
Indicator
ACRE
SMTI
Relative Strength Index (RSI) 49.98 61.81
Support Level $4.65 $22.60
Resistance Level $5.15 $24.33
Average True Range (ATR) 0.13 1.42
MACD 0.02 0.18
Stochastic Oscillator 68.18 79.27

Price Performance

Historical Comparison
ACRE
SMTI

About ACRE Ares Commercial Real Estate Corporation

Ares Commercial Real Estate Corp is a specialty finance company and a Real Estate Investment Trust providing commercial real estate loans and related investments. It operates in one segment namely originating and managing a diversified portfolio of CRE debt-related investments. The group recognizes its revenues through the interest income it receives from loans.

About SMTI Sanara MedTech Inc.

Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.

Share on Social Networks: